US · Healthcare · Health Information Services
EPS came in at -3.49 against a street estimate of -4.10 — a beat of 14.9%.
Analysts rate Claritev Corporation a buy (4 buy, 1 hold, 0 sell out of 5) with an average price target of $46.00.
| Fund | Stake |
|---|---|
| H&F Corporate Investors VIII, Ltd. | 22.94% |
| Arini Captial Management Ltd | 18.11% |
| Ares Management LLC | 10.99% |
| PUBLIC INVESTMENT FUND | 7.56% |
| Beach Point Capital Management LP | 4.43% |
| BlackRock Inc | 4.27% |
| CPV Partners, LLC | 2.92% |
| Vanguard Capital Management, LLC | 2.50% |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Claritev Corporation — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-11-07.